Safety of trifluridine/tipiracil for metastatic colorectal cancer in African American patients participating in an expanded access program.

被引:0
|
作者
Philip, Philip Agop
Smaglo, Brandon George
El-Rayes, Bassel F.
Lesuisse, Christian
Makris, Lukas
机构
[1] Karmanos Canc Inst, Detroit, MI USA
[2] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
[3] Emory Univ, Winship Canc Inst, Dept Med Oncol, Atlanta, GA 30322 USA
[4] Taiho Oncol Inc, Princeton, NJ USA
[5] Stathmi Inc, New Hope, PA USA
关键词
D O I
10.1200/JCO.2017.35.15_suppl.e15039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15039
引用
收藏
页数:6
相关论文
共 50 条
  • [31] The Efficacy and Safety of Trifluridine/Tipiracil Treatment for Elderly Patients With Metastatic Colorectal Cancer in a Real-world Setting
    Shibutani, Masatsune
    En, Wang
    Okazaki, Yuki
    Kashiwagi, Shinichiro
    Fukuoka, Tatsunari
    Iseki, Yasuhito
    Hirakawa, Kosei
    Ohira, Masaichi
    ANTICANCER RESEARCH, 2021, 41 (12) : 6211 - 6216
  • [32] Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single Institution
    Kotani, Daisuke
    Shitara, Kohei
    Kawazoe, Akihito
    Fukuoka, Shota
    Kuboki, Yasutoshi
    Bando, Hideaki
    Okamoto, Wataru
    Kojima, Takashi
    Doi, Toshihiko
    Ohtsu, Atsushi
    Yoshino, Takayuki
    CLINICAL COLORECTAL CANCER, 2016, 15 (03) : E109 - E115
  • [33] Effectiveness, safety, and prognostic factors of trifluridine/tipiracil for the treatment of patients with metastatic colorectal cancer in routine clinical practice
    Martinez-Perez, Julia
    Espinosa-Montano, Marta
    Luque-Caro, Natalia
    Avino-Tarazona, Victoria
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (02) : 692 - +
  • [34] Real-world use of trifluridine/tipiracil for patients with metastatic colorectal cancer in Canada
    Samawi, H. H.
    Brezden-Masley, C.
    Afzal, A. R.
    Cheung, W. Y.
    Dolley, A.
    CURRENT ONCOLOGY, 2019, 26 (05) : 319 - +
  • [35] Profile of trifluridine/tipiracil hydrochloride in the treatment of metastatic colorectal cancer: efficacy, safety, and place in therapy
    Sunakawa, Yu
    Izawa, Naoki
    Mizukami, Takuro
    Horie, Yoshiki
    Hirakawa, Mami
    Arai, Hiroyuki
    Ogura, Takashi
    Tsuda, Takashi
    Nakajima, Takako Eguchi
    ONCOTARGETS AND THERAPY, 2017, 10 : 4599 - 4605
  • [36] A retrospective study of trifluridine/tipiracil in pretreated metastatic colorectal cancer patients in clinical practice
    Borelli, Beatrice
    Zucchelli, Gemma
    Rossini, Daniele
    Cremolini, Chiara
    Antoniotti, Carlotta
    Moretto, Roberto
    Marmorino, Federica
    Colombo, Camilla
    Vannini, Francesca
    Delliponti, Laura
    Spione, Mario
    Ongaro, Elena
    Masi, Gianluca
    Brunetti, Isa Maura
    Pfanner, Elisabetta
    Salvatore, Lisa
    Falcone, Alfredo
    COLORECTAL CANCER, 2018, 7 (01)
  • [37] Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients
    Takahashi, Toshiaki
    Shigeyasu, Kunitoshi
    Kondo, Yoshitaka
    Takeda, Sho
    Umeda, Hibiki
    Moriwake, Kazuya
    Kayano, Masashi
    Sakurai, Yuya
    Nakamura, Shunsuke
    Takahashi, Masafumi
    Nitta, Kaori
    Yoshida, Kazuhiro
    Matsumi, Yuki
    Michiue, Hiroyuki
    Yamamoto, Hideki
    Kishimoto, Hiroyuki
    Teraishi, Fuminori
    Shoji, Ryohei
    Kanaya, Nobuhiko
    Kashima, Hajime
    Kakiuchi, Yoshihiko
    Kuroda, Shinji
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    BMC CANCER, 2025, 25 (01)
  • [38] Post-marketing surveillance study of trifluridine/tipiracil in patients with metastatic colorectal cancer
    Yoshino, Takayuki
    Uetake, Hiroyuki
    Funato, Yuya
    Yamaguchi, Yasunobu
    Koyama, Takahiko
    Ozawa, Daisuke
    Tajiri, Masaru
    Muro, Kei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (05) : 700 - 706
  • [39] RAS mutation specific survival in patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Grell, Peter
    Batko, Stanislav
    Pirsthuk, Alina
    Borilova, Simona
    Polachova, Katerina
    Mazuchova, Blanka
    Tomasek, Jiri
    Fabian, Pavel
    Berkovcova, Jitka
    Bardelcik, Miroslav
    Obermannova, Radka
    Buchler, Tomas
    Kiss, Igor
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL)
  • [40] QTWiST analysis of the RECOURSE trial of trifluridine/tipiracil in metastatic colorectal cancer
    Tabernero, Josep
    Van Cutsem, Eric
    Ohtsu, Atsushi
    Amellal, Nadia
    Cadour, Stephanie
    Fougeray, Ronan
    Haffemayer, Benjamin
    Mayer, Robert J.
    ESMO OPEN, 2017, 2 (05)